Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Altus Pharmaceuticals Inc. | 440,000 | reported | 19 Feb 2009 | tx 6+2,900,000−440,000 |
| GENZYME CORP | 46,535 | reported | 30 Oct 2007 | tx 21+261,565−83,065 |
| ADOLOR CORP | 32,406 | reported | 07 Dec 2011 | tx 24+352,406−297,406 |
| SUPERNUS PHARMACEUTICALS, INC. | 27,277 | reported | 06 Mar 2026 | tx 46+245,089−137,412 |
| Disc Medicine, Inc. | 1,000 | reported | 16 Sept 2025 | tx 9+914,635 |
| Dimension Therapeutics, Inc. | 0 | reported | 07 Nov 2017 | tx 5+49,069−93,543 |
| NPS PHARMACEUTICALS INC | 0 | reported | 21 Feb 2015 | tx 15+100,888−96,316 |
| MOMENTA PHARMACEUTICALS INC | 0 | reported | 01 Oct 2020 | tx 23+140,242−144,242 |
| AXONYX INC | 0 | reported | 25 Oct 2016 | tx 7+58,337−18,337 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 53.71 USD | |
| 06 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 8,787 | 53.00 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,905 | 25.30 USD | |
| 06 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,905 | 0.00 USD | deriv |
| 23 Feb 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 12.98 USD | |
| 24 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | |
| 23 Feb 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 24 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 2,989 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,977 | 0.00 USD | deriv |
| 16 Sept 2025 | GRANT_AWARD | Disc Medicine, Inc. | 1,000 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Disc Medicine, Inc. | 10,000 | 0.00 USD | deriv |
| 22 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | |
| 22 Feb 2025 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 7,296 | 0.00 USD | deriv |
| 08 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,787 | 11.46 USD | |
| 08 Nov 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10,787 | 36.30 USD | |
| 08 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,787 | 0.00 USD | deriv |
| 07 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 14,213 | 11.46 USD | |
| 07 Nov 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 14,213 | 36.62 USD | |
| 07 Nov 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 14,213 | 0.00 USD | deriv |
| 13 Sept 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 3,886 | 31.33 USD | |
| 13 Sept 2024 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 11.46 USD | |
| 13 Sept 2024 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 10,000 | 31.33 USD |